|
|
|
|
|
|
Sponsored by: |
Pennington Biomedical Research Center |
Information provided by: | Pennington Biomedical Research Center |
ClinicalTrials.gov Identifier: | NCT00477854 |
The purpose of this study is to test the effects of chromium picolinate on food intake, food cravings, eating attitudes, and appetite. If chromium picolinate is found to have a beneficial impact on satiety and food intake, then this supplement may be an alternative or adjunctive treatment for overweight people desiring to modify their food intake. The primary hypothesis of this study is that among individuals who report being carbohydrate cravers, chromium picolinate supplementation will reduce food intake during a test lunch meal and produce greater satiety in comparison to a placebo.
Condition | Intervention |
Obesity Atypical Depression |
Drug: Chromium Picolinate |
MedlinePlus related topics: | Depression Obesity |
ChemIDplus related topics: | Chromium Chromium picolinate |
Study Type: | Interventional |
Study Design: | Prevention, Randomized, Double-Blind, Placebo Control, Parallel Assignment |
Ages Eligible for Study: | 18 Years to 50 Years |
Genders Eligible for Study: | Female |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Inclusion criteria are:
Exclusion Criteria:
Potential participants will be excluded for the following reasons:
United States, Louisiana | |||||
Pennington Biomedical Research Center | |||||
Baton Rouge, Louisiana, United States, 70808 |
Pennington Biomedical Research Center |
Principal Investigator: | Stephen D Anton, Ph.D. | Pennington Biomedical Research Center |
Study ID Numbers: | 24040 |
First Received: | May 23, 2007 |
Last Updated: | May 23, 2007 |
ClinicalTrials.gov Identifier: | NCT00477854 |
Health Authority: | United States: Institutional Review Board |
|
|
|
|